Insight into the Significance ofAspergillus fumigatus cyp51APolymorphisms
ABSTRACTTriazole antifungal compounds are the first treatment choice for invasive aspergillosis. However, in the last decade the rate of azole resistance amongAspergillus fumigatusstrains has increased notoriously. The main resistance mechanisms are well defined and mostly related to point mutations of the azole target, 14-α sterol demethylase (cyp51A), with or without tandem repeat integrations in thecyp51Apromoter. Furthermore, different combinations of five Cyp51A mutations (F46Y, M172V, N248T, D255E, and E427K) have been reported worldwide in about 10% of allA. fumigatusisolates tested. The azole susceptibility profile of these strains shows elevated azole MICs, although on the basis of the azole susceptibility breakpoints, these strains are not considered azole resistant. The purpose of the study was to determine whether thesecyp51Apolymorphisms (single nucleotide polymorphisms [SNPs]) are responsible for the azole susceptibility profile and whether they are reflected in a poorer azole treatment responsein vivothat could compromise patient treatment and outcome. A mutant with acyp51Adeletion was generated and became fully susceptible to all azoles tested. Also, threecyp51Agene constructions with different combinations of SNPs were generated and reintroduced into an azole-susceptible wild-type (WT) strain (the ΔakuBKU80strain). The alternative model hostGalleria mellonellawas used to compare the virulence and voriconazole response ofG. mellonellalarvae infected withA. fumigatusstrains with WTcyp51Aorcyp51Awith SNPs. All strains were pathogenic inG. mellonellalarvae, although they did not respond similarly to voriconazole therapeutic doses. Finally, the full genomes of these strains were sequenced and analyzed in comparison with those ofA. fumigatusWT strains, revealing that they belong to different strain clusters or lineages.